| Application no. and date | 11788077.3 (espacenet) (Federated) (European Patent Register), 20111027 | | Patent/reg. no. and date | DK/EP 2637670, 20170308 | | Publication date | 20130918 | | Priority no. and date | US 412229 P, 20101110 | | EP pub. no. and date |
EP 2637670 20130918 | | Effective date | | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | P2289DKEP | | Inventor | ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE,
NAGORSEN, Dirk, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE,
SCHEELE, Juergen, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE | | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61K 39/395 (2006.01) | | Title | FOREBYGGELSE AF UØNSKEDE HÆNDELSER FORÅRSAGET AF SPECIFIKKE CD3-BINDINGSDOMÆNER | | Int. application no. | EP2011068862 | | Int. publication no. | WO2012062596 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
